These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35127830)

  • 1. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation.
    Zou X; Guo B; Ling Q; Mo Z
    Front Mol Biosci; 2022; 9():832238. PubMed ID: 35127830
    [No Abstract]   [Full Text] [Related]  

  • 2. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
    Zou X; Guo Y; Mo Z
    Front Genet; 2022; 13():905988. PubMed ID: 36419829
    [No Abstract]   [Full Text] [Related]  

  • 3. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment.
    Liao G; Lv J; Ji A; Meng S; Chen C
    J Oncol; 2021; 2021():3336770. PubMed ID: 34531911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Zou X; Mo Z
    Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
    Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
    Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 9. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration.
    Tang YF; Qiao B; Huang YB; Wang M
    Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and expression of prognostic-related genes in kidney renal clear cell carcinoma and their possible regulatory mechanisms.
    Liu Q; Ding J
    Transl Androl Urol; 2024 Aug; 13(8):1566-1581. PubMed ID: 39280680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles and potential mechanisms of HCST in the prognosis and immunity of KIRC via comprehensive analysis.
    Wang W; Li S; Lin J; Guo X; Xie Y; Li W; Hao Y; Jiang X
    Am J Transl Res; 2022; 14(2):752-771. PubMed ID: 35273683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
    Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
    Front Genet; 2022; 13():978840. PubMed ID: 36186442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
    Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
    Front Immunol; 2022; 13():926461. PubMed ID: 36311770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma.
    Ying J; Hong H; Yu C; Jiang M; Ding D
    Medicine (Baltimore); 2023 Sep; 102(38):e34954. PubMed ID: 37746997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma.
    Hu Y; Gu Y; Song Y; Zhao Y; Wang J; Ma J; Sui F
    Mol Cell Probes; 2024 Jun; 75():101959. PubMed ID: 38579915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
    Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
    Front Genet; 2023; 14():1109991. PubMed ID: 36992705
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of expression profiles and prognostic significance for MMDS-related iron-sulfur proteins in renal clear cell carcinoma.
    Yang L; Chen YX; Li YY; Liu XJ; Jiang YM; Mai J
    Sci Rep; 2022 Nov; 12(1):19637. PubMed ID: 36385109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.